NCT01841996View on ClinicalTrials.gov

Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2013

Conditions
Onychomycosis
Interventions
DRUG

ME1111 solution

Once a day for 28 days

DRUG

Vehicle Solution

Once a day for 28 days

Trial Locations (2)

Unknown

Austin

College Station

Sponsors
All Listed Sponsors
lead

Meiji Seika Pharma Co., Ltd.

INDUSTRY